Benzimidazole derivatives and their use for modulating the gabaalpha receptor complex
申请人:Teuber Lene
公开号:US20090030018A1
公开(公告)日:2009-01-29
This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith.
The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABA
A
receptor complex, and in particular for combating anxiety and related diseases.
BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX
申请人:NEUROSEARCH A/S
公开号:EP1874758A1
公开(公告)日:2008-01-09
US7776900B2
申请人:——
公开号:US7776900B2
公开(公告)日:2010-08-17
[EN] BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX<br/>[FR] DÉRIVÉS DE BENZIMIDAZOLE ET UTILISATION DE CEUX-CI POUR MODULER LE COMPLEXE DU RÉCEPTEUR GABAA
申请人:NEUROSEARCH AS
公开号:WO2006111516A1
公开(公告)日:2006-10-26
[EN] This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex, and in particular for combating anxiety and related diseases. [FR] Cette invention concerne de nouveaux dérivés de benzimidazole, des compositions pharmaceutiques contenant ces composés et des procédés de traitement avec ceux-ci. Les composés de l'invention sont utiles dans le traitement de maladies et troubles du système nerveux central, lesquels sont sensibles à la modulation du complexe du récepteur GABAA, et en particulier pour lutter contre l'anxiété et des maladies apparentées.